MDM2 and cancer: The most recurrent genetic alterations in cancer are CNAs targeting oncogenes such as MDM2 and TRPM728,30–32, and we identified these tumor-associated amplifications in cfDNA via ddPCR in 1/3 and 1/8 cases, respectively.